Explore
With the continued threat of viral pandemics and the emergence of pathogens that resist current therapeutic agents, there is now, more than ever, a greater need to develop rationally designed antiviral agents. This book provides a scientific but easy-to-understand overview of various aspects of modern-day antiviral drug design. Readers will gain insight into broad-spectrum antiviral drug design for respiratory viruses such as SARS-CoV-2 and influenza A, as well as discussions of direct-acting antiviral drugs, high-throughput bioassay development, and molecular docking of natural products as novel antivirals. Other aspects discussed in this volume include the results of antiretroviral therapy, resistance and drug-sensitivity testing, and ethnoveterinary antiviral drug screening methods. One major strength of this book is its blend of computational and experimental approaches to the antiviral drug design problem. With these aspects covered in great detail, this book makes for an excellent reference guide for anyone interested in antiviral drug design research. This book will also serve as an excellent teaching aid for postgraduate studies on antiviral drugs and their structure-based drug design. As an open-access volume, the book will be valuable to researchers worldwide.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 0 times via unglue.it ebook links.
- 0 - pdf (CC BY) at intech-files.s3.amazonaws.com.
Keywords
- Nursing pharmacology
- Pharmacology
- thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQC Nursing::MQCM Nursing pharmacology
Links
DOI: 10.5772/intechopen.1012163Editions